Zhende Medical Co., Ltd.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003J31
CNY
73.61
-1.89 (-2.5%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
4,223.59
4,093.96
6,095.84
5,043.24
10,370.38
1,855.11
1,412.68
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
4,223.59
4,093.96
6,095.84
5,043.24
10,370.38
1,855.11
1,412.68
Raw Material Cost
2,922.47
2,796.62
4,076.88
3,380.02
5,539.27
1,285.36
994.70
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
514.52
929.48
1,073.59
818.73
743.38
364.74
245.96
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
31.60
30.91
34.57
27.14
22.84
30.23
25.03
Selling and Distribution Expenses
796.81
800.56
914.86
756.22
876.51
348.59
221.94
Other Expenses
-41.61
-82.78
-88.86
-70.01
-51.14
-34.64
-21.68
Total Expenditure (Excl Depreciation)
3,849.26
3,729.80
5,211.34
4,282.05
6,670.65
1,682.55
1,270.84
Operating Profit (PBDIT) excl Other Income
374.3
364.20000000000005
884.5
761.2
3699.7000000000003
172.60000000000002
141.8
Other Income
174.27
109.92
45.75
123.04
-40.19
57.52
43.98
Operating Profit (PBDIT)
776.83
569.55
1,052.47
993.48
3,684.92
288.44
239.61
Interest
31.60
30.91
34.57
27.14
22.84
30.23
25.03
Exceptional Items
-21.14
-74.81
-18.66
-3.03
-49.78
6.76
-1.03
Gross Profit (PBDT)
1,301.12
1,297.34
2,018.96
1,663.22
4,831.10
569.74
417.97
Depreciation
247.80
244.30
195.33
143.06
78.94
65.67
61.81
Profit Before Tax
476.29
219.52
803.91
820.25
3,533.36
199.30
151.74
Tax
78.25
5.49
99.96
99.00
561.19
22.65
21.68
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
385.17
198.40
679.88
595.86
2,549.45
156.89
130.20
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
385.17
198.40
679.88
595.86
2,549.45
156.89
130.20
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
12.04
15.00
21.88
125.08
422.45
19.69
-0.32
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
397.21
213.40
701.76
720.95
2,971.90
176.58
129.88
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
5,643.25
5,365.60
5,540.49
4,066.74
4,182.79
1,358.79
1,123.72
Earnings per share (EPS)
1.45
0.74
2.87
2.63
12.5
0.8
0.66
Diluted Earnings per share
1.45
0.74
2.87
2.63
12.5
0.8
0.66
Operating Profit Margin (Excl OI)
8.4%
5.26%
13.31%
14.42%
35.16%
8.91%
9.47%
Gross Profit Margin
17.14%
11.33%
16.39%
19.1%
34.83%
14.28%
15.12%
PAT Margin
9.12%
4.85%
11.15%
11.82%
24.58%
8.46%
9.22%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 3.17% vs -32.84% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 86.13% vs -69.59% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 31.11% vs -54.35% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 2.27% vs -10.69% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Zhende Medical Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
4,223.59
0
4,223.59
Other Operating Income
0.00
0.00
0.00
Total Operating income
4,223.59
0
4,223.59
Raw Material Cost
2,922.47
0
2,922.47
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
514.52
0
514.52
Power Cost
0
0
0.00
Manufacturing Expenses
31.60
0
31.60
Selling and Distribution Expenses
796.81
0
796.81
Other Expenses
-41.61
0.00
-41.61
Total Expenditure (Excl Depreciation)
3,849.26
0
3,849.26
Operating Profit (PBDIT) excl Other Income
374.32
0.00
374.32
Other Income
174.27
0
174.27
Operating Profit (PBDIT)
776.83
0
776.83
Interest
31.60
0
31.60
Exceptional Items
-21.14
0
-21.14
Gross Profit (PBDT)
1,301.12
0
1,301.12
Depreciation
247.80
0
247.80
Profit Before Tax
476.29
0
476.29
Tax
78.25
0
78.25
Provisions and contingencies
0
0
0.00
Profit After Tax
385.17
0
385.17
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
385.17
0
385.17
Share in Profit of Associates
0
0
0.00
Minority Interest
12.04
0
12.04
Other related items
0.00
0.00
0.00
Consolidated Net Profit
397.21
0
397.21
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
5,643.25
0
5,643.25
Earnings per share (EPS)
1.45
0
1.45
Diluted Earnings per share
1.45
0
1.45
Operating Profit Margin (Excl OI)
8.40%
0%
0.00
8.40%
Gross Profit Margin
17.14%
0%
0.00
17.14%
PAT Margin
9.12%
0%
0.00
9.12%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 422.36 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 3.17% vs -32.84% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 39.72 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 86.13% vs -69.59% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 60.26 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 31.11% vs -54.35% in Dec 2023

Annual - Interest
Interest 3.16 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 2.27% vs -10.69% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 8.40%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023